A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Latest Expert Opinions

General MM,Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Following NICE guidelines | An interview with Ceri Bygrave

Mar 29, 2018

Latest Drug Updates

Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Galinpepimut-S granted FDA orphan drug designation

May 11, 2018
Patients eligible for transplant,Patients non-eligible for transplant

Daratumumab approved by FDA for frontline use

May 8, 2018
Relapsed/refractory patients

Selinexor receives FDA fast track designation 

Apr 13, 2018

Where we are next

2018 ASCO Annual Meeting

June 1–5, 2018 | Chicago, IL

We will be attending the 2018 American Society of Clinical Oncology (ASCO) in Chicago. The annual meeting brings together oncology professionals from around the world to discuss the latest treatment modalities, therapies, and ongoing controversies in different diseases including Multiple Myeloma (MM). Stay tuned to the MM Hub to follow for our first-hand coverage.

Event Website

Map Data
Map data ©2018 Google
Map DataMap data ©2018 Google
Map data ©2018 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology